nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—exocrine gland—esophageal cancer	0.0632	0.212	CbGeAlD
Auranofin—PRDX5—neck—esophageal cancer	0.0404	0.135	CbGeAlD
Auranofin—PRDX5—epithelium—esophageal cancer	0.0275	0.0921	CbGeAlD
Auranofin—PRDX5—bronchus—esophageal cancer	0.0271	0.0907	CbGeAlD
Auranofin—PRDX5—trachea—esophageal cancer	0.0243	0.0815	CbGeAlD
Auranofin—PRDX5—digestive system—esophageal cancer	0.0209	0.0701	CbGeAlD
Auranofin—PRDX5—lung—esophageal cancer	0.0175	0.0585	CbGeAlD
Auranofin—IKBKB—bronchus—esophageal cancer	0.016	0.0537	CbGeAlD
Auranofin—IKBKB—smooth muscle tissue—esophageal cancer	0.0157	0.0526	CbGeAlD
Auranofin—IKBKB—digestive system—esophageal cancer	0.0124	0.0415	CbGeAlD
Auranofin—PRDX5—lymph node—esophageal cancer	0.0119	0.04	CbGeAlD
Auranofin—IKBKB—lung—esophageal cancer	0.0103	0.0347	CbGeAlD
Auranofin—IKBKB—lymph node—esophageal cancer	0.00707	0.0237	CbGeAlD
Auranofin—ALB—lymph node—esophageal cancer	0.00413	0.0138	CbGeAlD
Auranofin—Interstitial pneumonia—Methotrexate—esophageal cancer	0.00223	0.0349	CcSEcCtD
Auranofin—Proteinuria—Capecitabine—esophageal cancer	0.00164	0.0258	CcSEcCtD
Auranofin—Protein urine present—Capecitabine—esophageal cancer	0.00162	0.0255	CcSEcCtD
Auranofin—Interstitial lung disease—Methotrexate—esophageal cancer	0.00152	0.0239	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00142	0.0223	CcSEcCtD
Auranofin—Melaena—Capecitabine—esophageal cancer	0.00141	0.0222	CcSEcCtD
Auranofin—Gingivitis—Methotrexate—esophageal cancer	0.00137	0.0215	CcSEcCtD
Auranofin—Proteinuria—Methotrexate—esophageal cancer	0.00122	0.0192	CcSEcCtD
Auranofin—Protein urine present—Methotrexate—esophageal cancer	0.00121	0.019	CcSEcCtD
Auranofin—Pancytopenia—Cisplatin—esophageal cancer	0.00117	0.0183	CcSEcCtD
Auranofin—Glossitis—Methotrexate—esophageal cancer	0.00117	0.0183	CcSEcCtD
Auranofin—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00114	0.0179	CcSEcCtD
Auranofin—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00111	0.0175	CcSEcCtD
Auranofin—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00107	0.0169	CcSEcCtD
Auranofin—Stomatitis—Cisplatin—esophageal cancer	0.00107	0.0168	CcSEcCtD
Auranofin—Conjunctivitis—Cisplatin—esophageal cancer	0.00107	0.0167	CcSEcCtD
Auranofin—Melaena—Methotrexate—esophageal cancer	0.00105	0.0165	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00105	0.0165	CcSEcCtD
Auranofin—Aplastic anaemia—Methotrexate—esophageal cancer	0.00101	0.0159	CcSEcCtD
Auranofin—Visual impairment—Cisplatin—esophageal cancer	0.000949	0.0149	CcSEcCtD
Auranofin—Eye disorder—Cisplatin—esophageal cancer	0.00092	0.0144	CcSEcCtD
Auranofin—Dysphagia—Capecitabine—esophageal cancer	0.000906	0.0142	CcSEcCtD
Auranofin—Alopecia—Cisplatin—esophageal cancer	0.00087	0.0137	CcSEcCtD
Auranofin—Pancytopenia—Capecitabine—esophageal cancer	0.000861	0.0135	CcSEcCtD
Auranofin—Neutropenia—Capecitabine—esophageal cancer	0.000848	0.0133	CcSEcCtD
Auranofin—Flatulence—Cisplatin—esophageal cancer	0.000844	0.0133	CcSEcCtD
Auranofin—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000827	0.013	CcSEcCtD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—MYC—esophageal cancer	0.000824	0.00129	CbGpPWpGaD
Auranofin—Weight decreased—Capecitabine—esophageal cancer	0.00082	0.0129	CcSEcCtD
Auranofin—IKBKB—MyD88-independent cascade—TLR4—esophageal cancer	0.000819	0.00128	CbGpPWpGaD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—CDKN1A—esophageal cancer	0.000813	0.00127	CbGpPWpGaD
Auranofin—IKBKB—FAS (CD95) signaling pathway—PIK3CA—esophageal cancer	0.00081	0.00127	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—esophageal cancer	0.000806	0.00126	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—CASP8—esophageal cancer	0.000801	0.00126	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—esophageal cancer	0.000801	0.00125	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TLR4—esophageal cancer	0.0008	0.00125	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000792	0.0124	CcSEcCtD
Auranofin—Anaemia—Cisplatin—esophageal cancer	0.000792	0.0124	CcSEcCtD
Auranofin—Jaundice—Capecitabine—esophageal cancer	0.000788	0.0124	CcSEcCtD
Auranofin—Stomatitis—Capecitabine—esophageal cancer	0.000788	0.0124	CcSEcCtD
Auranofin—Conjunctivitis—Capecitabine—esophageal cancer	0.000786	0.0123	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—NOS3—esophageal cancer	0.000782	0.00123	CbGpPWpGaD
Auranofin—IKBKB—GMCSF-mediated signaling events—PIK3CA—esophageal cancer	0.000774	0.00121	CbGpPWpGaD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—EP300—esophageal cancer	0.000774	0.00121	CbGpPWpGaD
Auranofin—IKBKB—IL-4 Signaling Pathway—EP300—esophageal cancer	0.000774	0.00121	CbGpPWpGaD
Auranofin—Haematuria—Capecitabine—esophageal cancer	0.000771	0.0121	CcSEcCtD
Auranofin—Leukopenia—Cisplatin—esophageal cancer	0.000767	0.012	CcSEcCtD
Auranofin—Agranulocytosis—Capecitabine—esophageal cancer	0.000754	0.0118	CcSEcCtD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CASP8—esophageal cancer	0.000752	0.00118	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—SOD2—esophageal cancer	0.000746	0.00117	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—CASP8—esophageal cancer	0.000745	0.00117	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—CREBBP—esophageal cancer	0.000742	0.00116	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—TLR4—esophageal cancer	0.000737	0.00115	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—ERBB2—esophageal cancer	0.000731	0.00115	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFBR2—esophageal cancer	0.000724	0.00114	CbGpPWpGaD
Auranofin—IKBKB—Downstream TCR signaling—PIK3CA—esophageal cancer	0.000713	0.00112	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—CASP8—esophageal cancer	0.000703	0.0011	CbGpPWpGaD
Auranofin—Visual impairment—Capecitabine—esophageal cancer	0.000699	0.011	CcSEcCtD
Auranofin—IKBKB—Apoptosis—CDKN2A—esophageal cancer	0.000699	0.00109	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000695	0.00109	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—TLR4—esophageal cancer	0.000693	0.00109	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—BCL2—esophageal cancer	0.000688	0.00108	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PTPN2—esophageal cancer	0.000686	0.00108	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—CASP8—esophageal cancer	0.000686	0.00108	CbGpPWpGaD
Auranofin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000685	0.0108	CcSEcCtD
Auranofin—IKBKB—Cytokine Signaling in Immune system—B2M—esophageal cancer	0.000679	0.00106	CbGpPWpGaD
Auranofin—Eye disorder—Capecitabine—esophageal cancer	0.000678	0.0106	CcSEcCtD
Auranofin—Eosinophilia—Methotrexate—esophageal cancer	0.000668	0.0105	CcSEcCtD
Auranofin—Anorexia—Cisplatin—esophageal cancer	0.000667	0.0105	CcSEcCtD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—EP300—esophageal cancer	0.000659	0.00103	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CDKN2A—esophageal cancer	0.000655	0.00103	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PFN1—esophageal cancer	0.000651	0.00102	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CAPZA1—esophageal cancer	0.000649	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—CCND1—esophageal cancer	0.000646	0.00101	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—BCL2—esophageal cancer	0.000645	0.00101	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CAPZA1—esophageal cancer	0.000644	0.00101	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RNF6—esophageal cancer	0.000644	0.00101	CbGpPWpGaD
Auranofin—Alopecia—Capecitabine—esophageal cancer	0.000641	0.0101	CcSEcCtD
Auranofin—Pancytopenia—Methotrexate—esophageal cancer	0.000641	0.0101	CcSEcCtD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000635	0.000996	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—CASP8—esophageal cancer	0.000632	0.000991	CbGpPWpGaD
Auranofin—Neutropenia—Methotrexate—esophageal cancer	0.000631	0.00991	CcSEcCtD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TLR4—esophageal cancer	0.000624	0.000978	CbGpPWpGaD
Auranofin—Flatulence—Capecitabine—esophageal cancer	0.000622	0.00977	CcSEcCtD
Auranofin—Dysgeusia—Capecitabine—esophageal cancer	0.000619	0.00971	CcSEcCtD
Auranofin—IKBKB—Toll-Like Receptors Cascades—TLR4—esophageal cancer	0.000617	0.000967	CbGpPWpGaD
Auranofin—Decreased appetite—Cisplatin—esophageal cancer	0.000608	0.00954	CcSEcCtD
Auranofin—IKBKB—Adaptive Immune System—CTSC—esophageal cancer	0.000598	0.000938	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—CASP8—esophageal cancer	0.000595	0.000932	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000592	0.000928	CbGpPWpGaD
Auranofin—Stomatitis—Methotrexate—esophageal cancer	0.000586	0.00921	CcSEcCtD
Auranofin—Conjunctivitis—Methotrexate—esophageal cancer	0.000585	0.00918	CcSEcCtD
Auranofin—Anaemia—Capecitabine—esophageal cancer	0.000584	0.00917	CcSEcCtD
Auranofin—Haematuria—Methotrexate—esophageal cancer	0.000574	0.00901	CcSEcCtD
Auranofin—IKBKB—IL-4 Signaling Pathway—PIK3CA—esophageal cancer	0.000572	0.000897	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—MYC—esophageal cancer	0.000567	0.000889	CbGpPWpGaD
Auranofin—Leukopenia—Capecitabine—esophageal cancer	0.000565	0.00888	CcSEcCtD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—EP300—esophageal cancer	0.000565	0.000885	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—EGFR—esophageal cancer	0.000562	0.00088	CbGpPWpGaD
Auranofin—Agranulocytosis—Methotrexate—esophageal cancer	0.000561	0.00882	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—EGFR—esophageal cancer	0.000555	0.00087	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CASP8—esophageal cancer	0.000536	0.000839	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling—PIK3CA—esophageal cancer	0.000533	0.000836	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—CASP8—esophageal cancer	0.00053	0.00083	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—CFL1—esophageal cancer	0.000528	0.000827	CbGpPWpGaD
Auranofin—Visual impairment—Methotrexate—esophageal cancer	0.000521	0.00817	CcSEcCtD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—PIK3CA—esophageal cancer	0.000519	0.000814	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ELMO1—esophageal cancer	0.000514	0.000805	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TMEM173—esophageal cancer	0.000509	0.000798	CbGpPWpGaD
Auranofin—Eye disorder—Methotrexate—esophageal cancer	0.000505	0.00793	CcSEcCtD
Auranofin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000505	0.00792	CcSEcCtD
Auranofin—ALB—Platelet activation, signaling and aggregation—GNG7—esophageal cancer	0.000498	0.00078	CbGpPWpGaD
Auranofin—Anorexia—Capecitabine—esophageal cancer	0.000491	0.00772	CcSEcCtD
Auranofin—IKBKB—BCR signaling pathway—PIK3CA—esophageal cancer	0.000482	0.000755	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—PIK3CA—esophageal cancer	0.000482	0.000755	CbGpPWpGaD
Auranofin—Diarrhoea—Cisplatin—esophageal cancer	0.000478	0.00751	CcSEcCtD
Auranofin—Alopecia—Methotrexate—esophageal cancer	0.000477	0.00749	CcSEcCtD
Auranofin—IKBKB—Apoptosis—MYC—esophageal cancer	0.000473	0.000742	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—PIK3CA—esophageal cancer	0.00047	0.000737	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—esophageal cancer	0.000466	0.00073	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CFL1—esophageal cancer	0.000463	0.000726	CbGpPWpGaD
Auranofin—Dysgeusia—Methotrexate—esophageal cancer	0.00046	0.00723	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—CASP8—esophageal cancer	0.00046	0.000721	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GDI2—esophageal cancer	0.000455	0.000714	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—TP53—esophageal cancer	0.000455	0.000713	CbGpPWpGaD
Auranofin—Dyspepsia—Capecitabine—esophageal cancer	0.000454	0.00712	CcSEcCtD
Auranofin—Decreased appetite—Capecitabine—esophageal cancer	0.000448	0.00704	CcSEcCtD
Auranofin—Vomiting—Cisplatin—esophageal cancer	0.000445	0.00698	CcSEcCtD
Auranofin—IKBKB—Innate Immune System—LGALS3—esophageal cancer	0.000444	0.000696	CbGpPWpGaD
Auranofin—Rash—Cisplatin—esophageal cancer	0.000441	0.00692	CcSEcCtD
Auranofin—Constipation—Capecitabine—esophageal cancer	0.000441	0.00692	CcSEcCtD
Auranofin—Dermatitis—Cisplatin—esophageal cancer	0.000441	0.00692	CcSEcCtD
Auranofin—Anaemia—Methotrexate—esophageal cancer	0.000435	0.00682	CcSEcCtD
Auranofin—ALB—Hemostasis—ATP1B2—esophageal cancer	0.00043	0.000674	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAP3K3—esophageal cancer	0.000427	0.000669	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—MYC—esophageal cancer	0.000422	0.000661	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000422	0.00662	CcSEcCtD
Auranofin—Leukopenia—Methotrexate—esophageal cancer	0.000421	0.00661	CcSEcCtD
Auranofin—ALB—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000416	0.000653	CbGpPWpGaD
Auranofin—Nausea—Cisplatin—esophageal cancer	0.000415	0.00652	CcSEcCtD
Auranofin—Urticaria—Capecitabine—esophageal cancer	0.00041	0.00643	CcSEcCtD
Auranofin—Abdominal pain—Capecitabine—esophageal cancer	0.000408	0.0064	CcSEcCtD
Auranofin—ALB—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	0.000406	0.000636	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—PIK3CA—esophageal cancer	0.000402	0.00063	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000396	0.000621	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ACTB—esophageal cancer	0.000394	0.000618	CbGpPWpGaD
Auranofin—ALB—Hemostasis—DOCK2—esophageal cancer	0.000389	0.00061	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TP53—esophageal cancer	0.000389	0.000609	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—esophageal cancer	0.000386	0.000604	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—B2M—esophageal cancer	0.000381	0.000596	CbGpPWpGaD
Auranofin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000376	0.0059	CcSEcCtD
Auranofin—ALB—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000372	0.000584	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—ERBB2—esophageal cancer	0.000368	0.000577	CbGpPWpGaD
Auranofin—Anorexia—Methotrexate—esophageal cancer	0.000366	0.00574	CcSEcCtD
Auranofin—IKBKB—Adaptive Immune System—B2M—esophageal cancer	0.000365	0.000573	CbGpPWpGaD
Auranofin—Pruritus—Capecitabine—esophageal cancer	0.000365	0.00573	CcSEcCtD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—esophageal cancer	0.000365	0.000572	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTSC—esophageal cancer	0.000363	0.000569	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000353	0.000553	CbGpPWpGaD
Auranofin—Diarrhoea—Capecitabine—esophageal cancer	0.000353	0.00554	CcSEcCtD
Auranofin—IKBKB—Adaptive Immune System—PSME1—esophageal cancer	0.000345	0.000541	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PSME2—esophageal cancer	0.000345	0.000541	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—PIK3CA—esophageal cancer	0.000344	0.000539	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HSPA5—esophageal cancer	0.000342	0.000536	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—ERBB2—esophageal cancer	0.000341	0.000534	CbGpPWpGaD
Auranofin—Dyspepsia—Methotrexate—esophageal cancer	0.000338	0.0053	CcSEcCtD
Auranofin—ALB—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000337	0.000528	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PFN1—esophageal cancer	0.000336	0.000526	CbGpPWpGaD
Auranofin—Decreased appetite—Methotrexate—esophageal cancer	0.000334	0.00524	CcSEcCtD
Auranofin—ALB—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.000333	0.000521	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CALR—esophageal cancer	0.000331	0.000519	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—esophageal cancer	0.00033	0.000516	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KMT2D—esophageal cancer	0.000329	0.000516	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—PIK3CA—esophageal cancer	0.000329	0.000515	CbGpPWpGaD
Auranofin—Vomiting—Capecitabine—esophageal cancer	0.000328	0.00515	CcSEcCtD
Auranofin—Rash—Capecitabine—esophageal cancer	0.000325	0.0051	CcSEcCtD
Auranofin—Dermatitis—Capecitabine—esophageal cancer	0.000325	0.0051	CcSEcCtD
Auranofin—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000323	0.000506	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000323	0.000506	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FBXW7—esophageal cancer	0.00032	0.000502	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HMGB1—esophageal cancer	0.000319	0.0005	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—CDKN1A—esophageal cancer	0.000315	0.000493	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000314	0.00493	CcSEcCtD
Auranofin—Nausea—Capecitabine—esophageal cancer	0.000306	0.00481	CcSEcCtD
Auranofin—Urticaria—Methotrexate—esophageal cancer	0.000305	0.00479	CcSEcCtD
Auranofin—Abdominal pain—Methotrexate—esophageal cancer	0.000303	0.00476	CcSEcCtD
Auranofin—IKBKB—Immune System—ELMO1—esophageal cancer	0.000299	0.000469	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADCYAP1—esophageal cancer	0.000293	0.00046	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—CDKN1A—esophageal cancer	0.000291	0.000456	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000281	0.000441	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CFL1—esophageal cancer	0.000272	0.000426	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—esophageal cancer	0.000272	0.000426	CbGpPWpGaD
Auranofin—Pruritus—Methotrexate—esophageal cancer	0.000271	0.00426	CcSEcCtD
Auranofin—IKBKB—Immune System—CFL1—esophageal cancer	0.00027	0.000423	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—PIK3CA—esophageal cancer	0.000269	0.000421	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—WWOX—esophageal cancer	0.000268	0.000421	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—esophageal cancer	0.000267	0.000419	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—EGFR—esophageal cancer	0.000266	0.000417	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ABL1—esophageal cancer	0.000264	0.000413	CbGpPWpGaD
Auranofin—Diarrhoea—Methotrexate—esophageal cancer	0.000263	0.00412	CcSEcCtD
Auranofin—IKBKB—Immune System—LGALS3—esophageal cancer	0.000259	0.000405	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GNG7—esophageal cancer	0.000256	0.000402	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FKBP1A—esophageal cancer	0.000255	0.0004	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—esophageal cancer	0.000255	0.0004	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ERBB2—esophageal cancer	0.000251	0.000393	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—WIF1—esophageal cancer	0.00025	0.000391	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—esophageal cancer	0.000249	0.000391	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000245	0.000385	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000245	0.000383	CbGpPWpGaD
Auranofin—Vomiting—Methotrexate—esophageal cancer	0.000244	0.00383	CcSEcCtD
Auranofin—Rash—Methotrexate—esophageal cancer	0.000242	0.0038	CcSEcCtD
Auranofin—Dermatitis—Methotrexate—esophageal cancer	0.000242	0.0038	CcSEcCtD
Auranofin—IKBKB—Insulin Signaling—PIK3CA—esophageal cancer	0.00024	0.000376	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—EGFR—esophageal cancer	0.000236	0.00037	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—esophageal cancer	0.000232	0.000364	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CSNK1A1—esophageal cancer	0.00023	0.000361	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ACTB—esophageal cancer	0.00023	0.00036	CbGpPWpGaD
Auranofin—Nausea—Methotrexate—esophageal cancer	0.000228	0.00358	CcSEcCtD
Auranofin—IKBKB—Immune System—PTPN2—esophageal cancer	0.000224	0.000351	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—esophageal cancer	0.000223	0.00035	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000222	0.000348	CbGpPWpGaD
Auranofin—IKBKB—Immune System—B2M—esophageal cancer	0.000222	0.000347	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—esophageal cancer	0.000221	0.000347	CbGpPWpGaD
Auranofin—ALB—Metabolism—BLVRB—esophageal cancer	0.000218	0.000342	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC52A3—esophageal cancer	0.000218	0.000342	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PFN1—esophageal cancer	0.000215	0.000338	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CDKN1A—esophageal cancer	0.000214	0.000336	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PSME1—esophageal cancer	0.000209	0.000328	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PSME2—esophageal cancer	0.000209	0.000328	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HSPA5—esophageal cancer	0.000209	0.000328	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HSPA5—esophageal cancer	0.000207	0.000325	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PIK3CA—esophageal cancer	0.000205	0.000321	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CALR—esophageal cancer	0.000201	0.000315	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TLR4—esophageal cancer	0.0002	0.000313	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000195	0.000306	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FBXW7—esophageal cancer	0.000194	0.000305	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ELMO1—esophageal cancer	0.000193	0.000303	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKAP13—esophageal cancer	0.000189	0.000296	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HMGB1—esophageal cancer	0.000186	0.000291	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC10A2—esophageal cancer	0.000185	0.000291	CbGpPWpGaD
Auranofin—ALB—Metabolism—CA1—esophageal cancer	0.000185	0.000291	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000175	0.000274	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—esophageal cancer	0.000174	0.000272	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDE4D—esophageal cancer	0.000173	0.000271	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CASP8—esophageal cancer	0.000172	0.000269	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CREBBP—esophageal cancer	0.000171	0.000268	CbGpPWpGaD
Auranofin—ALB—Metabolism—CA2—esophageal cancer	0.00017	0.000266	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000166	0.00026	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GNG7—esophageal cancer	0.000165	0.000258	CbGpPWpGaD
Auranofin—ALB—Metabolism—ADH7—esophageal cancer	0.000158	0.000247	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLCE1—esophageal cancer	0.000158	0.000247	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000156	0.000244	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ABL1—esophageal cancer	0.000155	0.000243	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—XIAP—esophageal cancer	0.000154	0.000242	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ABL1—esophageal cancer	0.000154	0.000241	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CA—esophageal cancer	0.000153	0.00024	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CA—esophageal cancer	0.000151	0.000236	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—BCL2—esophageal cancer	0.000147	0.000231	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CTNNA1—esophageal cancer	0.000146	0.000228	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL2—esophageal cancer	0.000145	0.000227	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ERBB2—esophageal cancer	0.000143	0.000224	CbGpPWpGaD
Auranofin—ALB—Metabolism—ADH1B—esophageal cancer	0.000138	0.000217	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ERBB2—esophageal cancer	0.000137	0.000215	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PSME2—esophageal cancer	0.000135	0.000212	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PSME1—esophageal cancer	0.000135	0.000212	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000135	0.000212	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ANXA1—esophageal cancer	0.000135	0.000211	CbGpPWpGaD
Auranofin—ALB—Metabolism—TYMP—esophageal cancer	0.000132	0.000207	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SST—esophageal cancer	0.000131	0.000205	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00013	0.000203	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP26A1—esophageal cancer	0.000129	0.000201	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GHRL—esophageal cancer	0.000128	0.0002	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH3—esophageal cancer	0.000128	0.0002	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FBXW7—esophageal cancer	0.000126	0.000197	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALOX15—esophageal cancer	0.000125	0.000196	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1A—esophageal cancer	0.000122	0.000192	CbGpPWpGaD
Auranofin—ALB—Metabolism—TPI1—esophageal cancer	0.00012	0.000187	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTO1—esophageal cancer	0.00012	0.000187	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1A—esophageal cancer	0.000117	0.000184	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR4—esophageal cancer	0.000116	0.000182	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EP300—esophageal cancer	0.000116	0.000182	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALDOB—esophageal cancer	0.000115	0.00018	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH2—esophageal cancer	0.000115	0.00018	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS2—esophageal cancer	0.000112	0.000175	CbGpPWpGaD
Auranofin—ALB—Metabolism—GAPDH—esophageal cancer	0.00011	0.000173	CbGpPWpGaD
Auranofin—ALB—Metabolism—CRABP1—esophageal cancer	0.000109	0.000171	CbGpPWpGaD
Auranofin—ALB—Metabolism—GNG7—esophageal cancer	0.000104	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFBR2—esophageal cancer	0.000102	0.000159	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CREBBP—esophageal cancer	0.0001	0.000157	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CASP8—esophageal cancer	9.99e-05	0.000157	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CREBBP—esophageal cancer	9.94e-05	0.000156	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—esophageal cancer	9.91e-05	0.000155	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	9.8e-05	0.000154	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALDH2—esophageal cancer	9.74e-05	0.000153	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SMAD4—esophageal cancer	9.62e-05	0.000151	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—esophageal cancer	9.52e-05	0.000149	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTT1—esophageal cancer	9.27e-05	0.000145	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2A6—esophageal cancer	9.16e-05	0.000144	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.13e-05	0.000143	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS3—esophageal cancer	8.97e-05	0.000141	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS1—esophageal cancer	8.68e-05	0.000136	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO1—esophageal cancer	8.68e-05	0.000136	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.68e-05	0.000136	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CA—esophageal cancer	8.6e-05	0.000135	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL2—esophageal cancer	8.57e-05	0.000134	CbGpPWpGaD
Auranofin—ALB—Metabolism—PSME2—esophageal cancer	8.56e-05	0.000134	CbGpPWpGaD
Auranofin—ALB—Metabolism—PSME1—esophageal cancer	8.56e-05	0.000134	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB2—esophageal cancer	8.33e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CA—esophageal cancer	8.26e-05	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HIF1A—esophageal cancer	7.87e-05	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KDR—esophageal cancer	7.53e-05	0.000118	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.47e-05	0.000117	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP1B1—esophageal cancer	7.38e-05	0.000116	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1A—esophageal cancer	7.12e-05	0.000112	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH1—esophageal cancer	7.09e-05	0.000111	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP19A1—esophageal cancer	6.94e-05	0.000109	CbGpPWpGaD
Auranofin—ALB—Hemostasis—EP300—esophageal cancer	6.83e-05	0.000107	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EP300—esophageal cancer	6.77e-05	0.000106	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CREBBP—esophageal cancer	6.43e-05	0.000101	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMOX1—esophageal cancer	6.34e-05	9.93e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.21e-05	9.74e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCB1—esophageal cancer	6.08e-05	9.53e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—esophageal cancer	5.77e-05	9.05e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOS3—esophageal cancer	5.76e-05	9.02e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB2—esophageal cancer	5.38e-05	8.44e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CA—esophageal cancer	5.05e-05	7.91e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CA—esophageal cancer	5.01e-05	7.85e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—esophageal cancer	4.89e-05	7.66e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—esophageal cancer	4.76e-05	7.46e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1A—esophageal cancer	4.6e-05	7.21e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.6e-05	7.21e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EP300—esophageal cancer	4.38e-05	6.86e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CREBBP—esophageal cancer	4.06e-05	6.37e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—esophageal cancer	3.82e-05	5.98e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—esophageal cancer	3.73e-05	5.85e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NOS3—esophageal cancer	3.64e-05	5.7e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—esophageal cancer	3.33e-05	5.22e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CA—esophageal cancer	3.24e-05	5.08e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—esophageal cancer	3.13e-05	4.91e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—EP300—esophageal cancer	2.77e-05	4.34e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CA—esophageal cancer	2.05e-05	3.21e-05	CbGpPWpGaD
